Open Proposal Program
Get the resources you need to discover effective therapies for NF1.
NTAP invites innovative proposals from all investigators and inventors, regardless of their location or primary research focus. Funding through the Open Proposal Program is offered through two application cycles each year. If you have an idea for a compelling research project with the potential to accelerate therapeutics for NF1, we want to hear from you.
Scroll down the page to learn more about requirements, research priorities and how to apply or submit your letter of intent.
The past decade revealed that neurofibromin is a driver in common cancers. I believe that unlocking the science of NF1… will spawn breakthroughs in treatments for many cancers.
Frank McCormick, PhD, FRS, DSc (Hon)
David A. Wood Distinguished Professorship of Tumor Biology and Cancer Research
Professor, Helen Diller Family Comprehensive Cancer Center and Dept. of Cellular and Molecular Pharmacology
University of California, San Francisco
Priority Research Areas
- Novel Biology for NF1-Driven Tumors
- IND-Enabling Translational Drug Development
- Tumor Microenvironment and Symptom Management
- Adult NF1 & Lifespan Research
What funding includes
- Annual salary matched to/> NIH maximum cap
- Direct funding for research
- Up to 10% in indirect costs
